Thromboembolic disease Circulatory System Arterial embolism and thrombosis
Conditions
Interventions
A randomised controlled trial using 12 primary care practices in Birmingham, UK (9 intervention and 3 control). The study used 2 control populations
patients individually randomly allocated as controls in the intervention practices (intra-practice controls), and all patients in the 3 control practices (inter-practice controls), included to estimat
Sponsors
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: Patients receiving warfarin therapy (n=368)
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main outcome measure used was INR control determined by; number of tests performed within target INR range; point prevalence of patients achieving individual therapeutic INR targets; and individual proportion of time spent within therapeutic target range. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed